We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$138M
AUM Growth
-$2.5M
Cap. Flow
-$444K
Cap. Flow %
-0.32%
Top 10 Hldgs %
90.14%
Holding
46
New
6
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
RLYP
RELYPSA INC COM
RLYP
+$316K
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$164K
3
MCRB icon
Seres Therapeutics
MCRB
+$147K
4
ALDR
Alder Biopharmaceuticals
ALDR
+$139K
5
WKHS icon
Workhorse Group
WKHS
+$118K

Top Sells

Rank Stock Value
1
COLL icon
Collegium Pharmaceutical
COLL
+$1.39M
2
KURA icon
Kura Oncology
KURA
+$62.2K

Sector Composition

Rank Sector Weight
1 Healthcare 91.54%
2 Energy 3.85%
3 Consumer Staples 1.23%
4 Consumer Discretionary 0.07%
5 Industrials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELGZ
26
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$348K 0.25%
238,214
– –
RLYP
27
DELISTED
RELYPSA INC COM
RLYP
$333K 0.24%
+18,000
New +$316K
ADXS
28
DELISTED
Advaxis Inc
ADXS
$288K 0.21%
2,373
– –
BIIB icon
29
Biogen
BIIB
$29.5B
$242K 0.18%
1,000
– –
MACK
30
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$237K 0.17%
5,592
– –
XNCR icon
31
Xencor
XNCR
$1.39B
$234K 0.17%
12,300
– –
RPTP
32
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$215K 0.16%
40,000
– –
TTHI
33
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$214K 0.16%
145,746
– –
PACB icon
34
Pacific Biosciences
PACB
$422M
$190K 0.14%
27,000
– –
ICPT
35
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$185K 0.13%
1,300
– –
CERS icon
36
Cerus
CERS
$631M
$165K 0.12%
26,500
– –
KURA icon
37
Kura Oncology
KURA
$948M
$160K 0.12%
59,114
-20,000
-25% -$62.2K
GNCA
38
DELISTED
Genocea Biosciences, Inc.
GNCA
$160K 0.12%
4,875
– –
PRTK
39
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$155K 0.11%
+11,150
New +$164K
MCRB icon
40
Seres Therapeutics
MCRB
$49.5M
$145K 0.11%
+250
New +$147K
ROKA
41
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$144K 0.1%
25,231
– –
ALDR
42
DELISTED
Alder Biopharmaceuticals
ALDR
$129K 0.09%
+5,150
New +$139K
CHRS icon
43
Coherus Oncology
CHRS
$219M
$127K 0.09%
7,500
– –
WKHS icon
44
Workhorse Group
WKHS
$30.1M
$103K 0.07%
+5
New +$118K
SITO
45
DELISTED
SITO MOBILE, LTD
SITO
$72K 0.05%
+20,000
New +$60.3K
COLL icon
46
Collegium Pharmaceutical
COLL
$1.15B
– –
-76,768
Closed -$1.39M
1
2

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Birchview Capital held 46 positions worth $138M, down 1.8% from $140M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Birchview Capital's Q2 2016 filing shows 6 new, 1 increased, 1 reduced and 1 closed positions. Its largest new stake was RELYPSA INC COM: 18,000 shares worth $333K. The largest sale was Collegium Pharmaceutical, an estimated $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 92% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q2 2016 buy was RELYPSA INC COM: 18,000 shares worth $333K.
  • Birchview Capital added most to TESARO, Inc. in Q2 2016, an estimated $66.9K increase.
  • Birchview Capital's biggest Q2 2016 reduction was Kura Oncology, cutting an estimated $62.2K.
  • Birchview Capital fully exited Collegium Pharmaceutical in Q2 2016, selling an estimated $1.39M.
  • Birchview Capital's ten largest holdings make up 90% of its $138M portfolio in Q2 2016.
  • Birchview Capital opened 6 new positions and closed 1 in Q2 2016.
  • Birchview Capital's portfolio value fell 1.8% quarter-over-quarter to $138M.

Based on Birchview Capital's 13F filing for Q2 2016, filed 9 Aug 2016.